Your browser doesn't support javascript.
loading
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis.
Rajoli, Rajith K R; Pertinez, Henry; Arshad, Usman; Box, Helen; Tatham, Lee; Curley, Paul; Neary, Megan; Sharp, Joanne; Liptrott, Neill J; Valentijn, Anthony; David, Christopher; Rannard, Steven P; Aljayyoussi, Ghaith; Pennington, Shaun H; Hill, Andrew; Boffito, Marta; Ward, Steve A; Khoo, Saye H; Bray, Patrick G; O'Neill, Paul M; Hong, W David; Biagini, Giancarlo A; Owen, Andrew.
Afiliación
  • Rajoli RKR; Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, UK.
  • Pertinez H; Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, UK.
  • Arshad U; Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, UK.
  • Box H; Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, UK.
  • Tatham L; Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, UK.
  • Curley P; Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, UK.
  • Neary M; Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, UK.
  • Sharp J; Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, UK.
  • Liptrott NJ; Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, UK.
  • Valentijn A; Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, UK.
  • David C; Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, UK.
  • Rannard SP; Department of Chemistry, University of Liverpool, Liverpool, UK.
  • Aljayyoussi G; Centre for Drugs and Diagnostics, and Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Pennington SH; Centre for Drugs and Diagnostics, and Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Hill A; Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, UK.
  • Boffito M; Chelsea and Westminster NHS Foundation Trust and St Stephen's AIDS Trust 4th Floor, Chelsea and Westminster Hospital, London, UK.
  • Ward SA; Jefferiss Research Trust Laboratories, Department of Medicine, Imperial College, London, UK.
  • Khoo SH; Centre for Drugs and Diagnostics, and Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Bray PG; Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, UK.
  • O'Neill PM; Pat Bray Electrical, Orrell, Wigan, UK.
  • Hong WD; Department of Chemistry, University of Liverpool, Liverpool, UK.
  • Biagini GA; Department of Chemistry, University of Liverpool, Liverpool, UK.
  • Owen A; Centre for Drugs and Diagnostics, and Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
Br J Clin Pharmacol ; 87(4): 2078-2088, 2021 04.
Article en En | MEDLINE | ID: mdl-33085781

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Tiazoles / Reposicionamiento de Medicamentos / COVID-19 / Tratamiento Farmacológico de COVID-19 / Modelos Biológicos / Nitrocompuestos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Clin Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Tiazoles / Reposicionamiento de Medicamentos / COVID-19 / Tratamiento Farmacológico de COVID-19 / Modelos Biológicos / Nitrocompuestos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Clin Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido